InMed Pharmaceuticals Inc. Annual Revenues in USD from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
InMed Pharmaceuticals Inc. quarterly/annual Revenues history and growth rate from 2022 to 2024.
  • InMed Pharmaceuticals Inc. Revenues for the quarter ending September 30, 2024 was $1.26M, a 40.2% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Revenues for 2024 was $4.6M, a 11.2% increase from 2023.
  • InMed Pharmaceuticals Inc. annual Revenues for 2023 was $4.14M, a 280% increase from 2022.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.6M +$462K +11.2% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-30
2023 $4.14M +$3.05M +280% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-30
2022 $1.09M Jul 1, 2021 Jun 30, 2022 10-K 2023-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.